Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 5/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6685026 | 0.83 | EPHX1 (0.37) | EPHX1NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL7076784 | 0.81 | — | — | |
| SCHEMBL6683030 | 0.80 | EPHX1 (0.32) | EPHX1NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL6830607 | 0.78 | EPHX1 (0.33) | EPHX1NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL6830058 | 0.77 | EPHX1 (0.30) | EPHX1NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL6832554 | 0.74 | EPHX1 (0.31) | EPHX1NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL6685928 | 0.72 | — | — | |
| SCHEMBL7739914 | 0.71 | EPHX1 (0.41) | EPHX1NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL7741299 | 0.68 | CES2 (0.38) | EPHX1NPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL27521452 | 0.67 | ALDH1A1 (0.46) | EPHX1SMN1; SMN2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003060191-A2 | NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |